Victory Capital Management Inc Arca Biopharma, Inc. Transaction History

Victory Capital Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$2.69 - $19.21 $691 - $4,936	-257 Closed	0 $0
Q1 2020 May 04, 2020	SELL	$2.32 - $6.42 $13 - $38	-6 Reduced 2.28%	257 $1,000
Q4 2019 Feb 04, 2020	BUY	$4.95 - $5.96 $143 - $172	29 Added 12.39%	263 $1,000
Q3 2019 Nov 12, 2019	BUY	$4.95 - $7.2 $1,158 - $1,684	234 New	234 $1,000

280K

Ticker ABIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,410,100
Description
ARCA biopharma, Inc., a clinical-stage biopharmaceutical company, develops and commercializes genetically targeted therapies for cardiovascular diseases. Its lead product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), which is in Phase IIb clinical trial for the treatment for COVID-19; and Gencaro (bucindolol hydr...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.